SCHEMBL9130707

SCHEMBL9130707

CCOP(C)(=O)C(C/C=C(\C)CCC=C(C)C)P(=O)(O)O

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FNTA P49354 2/20 0.48
FNTB P49356 2/20 0.48
PGGT1B P53609 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9127713 0.99 FNTA (0.50) FNTAFNTBPGGT1B
SCHEMBL9129879 0.85
SCHEMBL9128025 0.85
SCHEMBL9130655 0.85
SCHEMBL9129590 0.84
SCHEMBL9129378 0.84
SCHEMBL9127288 0.84 FNTA (0.53) FNTAFNTB
SCHEMBL5400265 0.83 FNTA (0.56) FNTAFNTB
SCHEMBL8916847 0.83 FNTA (0.56) FNTAFNTB
SCHEMBL8916855 0.83 FNTA (0.56) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5428028-A Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor E. R. SQUIBB & SONS, INC. (US) 1995-06-27 US disclosed
EP-0514124-A2 Use of phosphonomethylphosphinate squalene synthetase inhibitors for the manufacture of a medicament for the lowering cholesterol E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP disclosed